Loblaw Companies (TSE:L – Get Free Report) had its target price decreased by research analysts at UBS Group from C$225.00 to C$210.00 in a research note issued to investors on Friday,BayStreet.CA reports. UBS Group’s price target suggests a potential upside of 20.68% from the stock’s current price.
A number of other analysts also recently issued reports on L. CIBC raised their price target on shares of Loblaw Companies from C$206.00 to C$208.00 in a report on Friday. Royal Bank of Canada increased their price objective on shares of Loblaw Companies from C$205.00 to C$217.00 and gave the stock an “outperform” rating in a research note on Monday, December 9th. Desjardins increased their price objective on shares of Loblaw Companies from C$172.00 to C$190.00 in a research note on Thursday, November 14th. National Bankshares increased their price objective on shares of Loblaw Companies from C$188.00 to C$195.00 in a research note on Thursday, November 14th. Finally, TD Securities lowered their price objective on shares of Loblaw Companies from C$202.00 to C$195.00 in a research note on Friday. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Loblaw Companies presently has a consensus rating of “Moderate Buy” and an average target price of C$199.38.
Loblaw Companies Stock Down 0.4 %
Insider Activity
In other Loblaw Companies news, Director Christie James Beckett Clark sold 2,105 shares of Loblaw Companies stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of C$189.69, for a total transaction of C$399,297.45. Company insiders own 53.77% of the company’s stock.
About Loblaw Companies
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Further Reading
- Five stocks we like better than Loblaw Companies
- Stock Splits, Do They Really Impact Investors?
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.